Laddar...
AR collaborates with ERα in aromatase inhibitor-resistant breast cancer
Androgen receptor (AR) is an attractive target in breast cancer because of its frequent expression in all the molecular subtypes, especially in estrogen receptor (ER)-positive luminal breast cancers. We have previously shown a role for AR overexpression in tamoxifen resistance. We engineered ER-posi...
Sparad:
| I publikationen: | Breast Cancer Res Treat |
|---|---|
| Huvudupphovsmän: | , , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
2014
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4337991/ https://ncbi.nlm.nih.gov/pubmed/25178514 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-014-3082-8 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|